Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California. The post FDA Approves First At-Home Cervical Cancer Test appeared first on MedCity News.
This new approach is helping payors and providers unlock new value from their VBC initiatives while offering more effective and condition-specific treatment for patients. The post Evolving Markets, Innovative Solutions: The Rise of Specialty VBC appeared first on MedCity News.
More than 4 million Highmark commercial members now have access to AppliedVR’s RelieVRx as a covered therapeutic. The post Highmark Covers AppliedVR’s Product for Chronic Low Back Pain appeared first on MedCity News.
Obesity care company knownwell expanded into six new clinic locations across greater Chicago. The company now operates eight clinics, as it has existing locations in Boston and Dallas. Knownwell also provides virtual care services to patients across New England, Texas and Illinois. The post Knownwell Opens 6 New Clinics in Chicago appeared first on MedCity…
Through community engagement, the root causes of healthcare disparities can be addressed, and the health and resiliency of individuals can be dramatically improved. The post Increasing Health Equity Through Accessibility and Education appeared first on MedCity News.
EHR switching involves risk. But taking a life cycle view, considering data migration, workflow configuration, training, downtime, ongoing fees and eventual exit terms, can put an end to your EHR pain. The post What Healthcare Leaders Get Wrong About EHR Switching appeared first on MedCity News.
The MedTech industry has demonstrated remarkable resilience in navigating uncertainty, and 2025 promises to be a pivotal year as the election supercycle concludes and AI regulatory frameworks become clearer. The post 10 Key MedTech Themes for 2025 appeared first on MedCity News.
Johnson & Johnson is acquiring Halda Therapeutics for its lead program, a drug that recently posted encouraging Phase 1 data in advanced prostate cancer. This drug comes from a proprietary Halda platform technology that yields oral small molecules offering a novel mechanism for killing cancer cells. The post J&J’s $3B Halda Acquisition Brings a Way…
ATLANTA — Public health officials watched with dread as a panel shaped by the Trump administration took up an agenda to begin dismantling six decades of vaccination development and progress. But while the result seemed foretold, the debate was far from unanimous. The Advisory Committee on Immunization Practices, or ACIP, met at a satellite campus…
The first Phase 3 results for Eli Lilly’s daily pill orforglipron show statistically significant reductions in blood sugar and body weight in patients with type 2 diabetes. The pharmaceutical giant plans global regulatory submissions starting at the end of this year. The post Eli Lilly’s Metabolic Medicine Takes the Lead in the Race to Develop…